SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $10,152,000 | +70.3% | 229,117 | +187.7% | 6.10% | +97.9% |
Q1 2021 | $5,962,000 | -62.1% | 79,650 | -56.2% | 3.08% | -57.0% |
Q4 2020 | $15,715,000 | +151.0% | 181,650 | +77.3% | 7.17% | +78.0% |
Q3 2020 | $6,262,000 | -23.7% | 102,462 | -48.1% | 4.02% | -35.9% |
Q2 2020 | $8,202,000 | – | 197,249 | – | 6.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |